Agomelatine for the Treatment of Patients with Fibromyalgia and Depressive Symptomatology: An Uncontrolled, 12-Week, Pilot Study

  • E. Calandre, M. Slim, J. Garcia-Leiva, C. Rodriguez-Lopez, P. Torres, F. Rico-Villademoros
  • Pharmacopsychiatry, February 2014, Thieme Publishing Group
  • DOI: 10.1055/s-0033-1363659

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1055/s-0033-1363659

The following have contributed to this page: Professor Elena Pita Calandre